Form 4: Theravance Biopharma Executive Sells Shares
Insider Transaction (Form 4)
Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc., sold 13,314 shares of common stock on September 15, 2026.
Summary
- Open-market sale: disposed of 3,329 Ordinary Shares at $17.03 ($56,707) on September 15, 2026; holds 223,461 after (Direct).
- Open-market sale: disposed of 3,328 Ordinary Shares at $17.03 ($56,690) on September 15, 2026; holds 220,133 after (Direct).
- Open-market sale: disposed of 6,657 Ordinary Shares at $17.03 ($113,397) on September 15, 2026; holds 213,476 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $226,793 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Rhonda Farnum — Officer (SVP, COMM & MEDICAL AFFAIRS)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-15 | Open-market sale | Ordinary Shares | 3,329 | $17 | $56.7K | 223,461 |
| 2026-09-15 | Open-market sale | Ordinary Shares | 3,328 | $17 | $56.7K | 220,133 |
| 2026-09-15 | Open-market sale | Ordinary Shares | 6,657 | $17 | $113.4K | 213,476 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-15 | Open-market sale (3,329 shares) |
| 2026-09-15 | Open-market sale (3,328 shares) |
| 2026-09-15 | Open-market sale (6,657 shares) |
Keywords
insider transaction, Form 4, TBPH, Theravance Biopharma, Inc., bearish, Rhonda Farnum
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.